- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Berkeley Lights beams on to public markets
UC Berkeley-linked cell biology technology developer Berkeley Lights floated in a $178m offering and its shares almost tripled in price on their first day of trading.
Jul 20, 2020Xiaopeng gets passengers for $500m round
The smart electric carmaker, which counts Alibaba, Xiaomi and Foxconn as investors, is raising roughly $500m in a series C-plus round.
Jul 20, 2020Berkeley Lights beams on to public markets
The Nikon and Varian-backed cell biology technology developer floated in a $178m offering and its shares almost tripled in price on their first day of trading.
Jul 20, 2020CureVac cuts $176m equity deal with GSK
GlaxoSmithKline is paying $176m for a 10% stake in the RNA drug developer in connection with a strategic partnership agreement.
Jul 20, 2020Pandion stands up in $135m IPO
The Roche and GSK-backed autoimmune disease drug developer has gone public in an upsized initial public offering after at least $138m in earlier funding.
Jul 20, 2020Coursera enrols in $130m series F round
Seek Group returned for a series F round that reportedly more than doubled the adult education provider's valuation to $2.5bn.
Jul 20, 2020Spin Memory executes extra series B cash
NYU-founded Spin Memory has now raised $60.3m in series B capital, having lured the return of Allied Minds, Arm and Applied Ventures.
Jul 20, 2020TileDB structures $15m series A
Based on joint research at MIT and Intel Labs, the data analytics engine provider has now raised $20m in all after a round featuring Intel Capital.
Jul 20, 2020Cityblock receives series B-plus funding
Alphabet and EmblemHealth returned to help supply $53.5m for the community-focused care provider, bringing its overall funding to nearly $140m.
Jul 20, 2020Adagio tunes up with $50m
Adimab's coronavirus antibody spinoff has launched with series A financing from investors including GV as it prepares for its first clinical trials.
Jul 20, 2020Gem shines with $37m series B
The WndrCo-backed recruitment platform developer has taken its total funding to $48m with a round announced alongside a new diversity tool.
Jul 20, 2020Topgen ropes in CAS for series C
Chinese Academy of Sciences' Cash Holdings invested with its affiliate fund Guoke Ruihua to aid Shanghai Topgen's biotech development.
Jul 20, 2020Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
